Insider · CIK 0001873988
Mace Rothenberg
Files at TNGX (Tango Therapeutics, Inc.), SRZN (Surrozen, Inc./DE). First filing Nov 18, 2024, latest Nov 18, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TNGX: Tango Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | TNGXbuy Tango Therapeutics, Inc. | $74k 20,000 shares | +178% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | TNGX Tango Therapeutics, Inc. | AGrant or award Common Stock | +6,250 | $0.00 | $0 | 37,500 | Jun 9, 2025 |
| Jun 5, 2025 | TNGX Tango Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +37,500 | $0.00 | $0 | 37,500 | Jun 9, 2025 |
| May 14, 2025 | SRZN Surrozen, Inc./DE | AGrant or award Option (right to buy)derivative | +1,333 | $0.00 | $0 | 1,333 | May 15, 2025 |
| Nov 14, 2024 | TNGX Tango Therapeutics, Inc. | POpen-market purchase Common Stock | +10,000 | $3.62 | $36k | 21,250 | Nov 18, 2024 |
| Nov 18, 2024 | TNGX Tango Therapeutics, Inc. | POpen-market purchase Common Stock | +10,000 | $3.78 | $38k | 31,250 | Nov 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.